Poorly Differentiated Thyroid Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11595Atezolizumab2Recruiting1
DB00112Bevacizumab2Recruiting1
DB08875Cabozantinib2Recruiting1
DB01229Paclitaxel2Recruiting1
DB08881Vemurafenib2Recruiting1